Target intelligence / Profile preview

Complement component 1, q subcomponent binding protein (C1QBP) (C1QBP)

Target
C1QBP
Molecular classification
Mitochondrial protein, Receptor, Chaperone
01

Overview

Complement component 1, q subcomponent binding protein (C1QBP), also known as p32 or gC1qR, is a highly acidic, multifunctional protein primarily localized within the mitochondrial matrix, though it also resides in the nucleus, cytosol, and on the cell surface. It is essential for the maintenance of mitochondrial oxidative phosphorylation (OXPHOS) by regulating the translation of mitochondrial-encoded polypeptides. In many cancers, C1QBP is significantly overexpressed and translocated to the plasma membrane, where it serves as a receptor for ligands like C1q, hyaluronan, and various viral proteins, promoting tumor progression, angiogenesis, and metabolic reprogramming. Because of its preferential expression on the surface of tumor cells and tumor-associated macrophages, it is a target for diagnostic imaging and targeted therapy using peptides like LyP-1 and specific monoclonal antibodies. Therapeutic modulation of C1QBP aims to disrupt mitochondrial energy production or trigger apoptosis in malignant cells while sparing normal tissues. However, its critical role in mitochondrial function poses challenges regarding potential toxicity in healthy, high-energy-demanding organs (PubMed: ).

Other names
p32gC1qRHABP1Hyaluronan-binding protein 1SF2-associated p32GC1QBPTAP
02

Mechanism of action

Inhibition of mitochondrial oxidative phosphorylation, blockade of cell surface receptor-ligand interactions, and induction of tumor-specific apoptosis.

03

Biological functions

Mitochondrial metabolismApoptosisImmune responseRNA splicingCell signalingOxidative phosphorylation
04

Disease associations

CancerInfectionInflammationCardiovascular diseaseMitochondrial disease
05

Safety considerations

Mitochondrial toxicityImpaired oxidative phosphorylation in healthy tissuesPotential immune system interference
06

Interacting drugs

LyP-1

2 more in the full profile.

07

Biomarkers

C1QBP overexpressionCell surface C1QBP expression

Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.

Beyond the preview

Go deeper on Complement component 1, q subcomponent binding protein (C1QBP) (C1QBP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Complement component 1, q subcomponent binding protein (C1QBP) (C1QBP).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call